gineco
ro
Bibliografie
1. Reaven GM. Role of insulin în human disease. Diabetes. 1988;37: 1595–1607
2. R Holmes, H Porter et al, An immunohistochemical study of type I Insulin-like
Growth Factor Receptors în the placentae of Pregnancies with appropriately
grown or growth restricted fetuses, Placenta (1999), 20, 325-30.
3. N.P. Illsleny, Glucose transporters în the human placenta, Placenta (2000), 21,
14-22.
4. A.M.Carter et al, The expression of Insulin like Growth Factor and Insulin like
Growth Factor Binding Protein mRNAs în mouse placenta, Placenta 2006, 27,
278-290
5. Vanessa E Murphy, Rofer Smith, Warwick Giles, Vicki Clifton, Endocrine regula-
tion of human fetal growth: the role of the mother, placenta and fetus, Endo-
crine Reviews, april 2006, 27: 141-169.
6. Weiss R, Dziura J, Burgert T, et al. Obesity and the metabolic syndrome în chil-
dren and adolescents. N Engl J Med. 2004;350:2362–2374
7. Toal M, Chan C, Fallah S, et al. Usefulness of a placental profile în high-risk preg-
nancies. Am J Obstet Gynecol 2007;196:363.e1-363.e7
8. Centers for Disease Control and Prevention. Update: prevalence of overweight
among children, adolescents, and adults: United States, 1988–1994. MMWR
Morb Mortal Wkly Rep. 1997;46:198–202
9. Ratner RE, et al. Amylin replacement with pramlintide as an adjunct to insulin
therapy improves long-term glycaemic and weight control în Type 1 diabetes
mellitus: a 1-year, randomized controlled trial (2004) Diabet Med 21 (11): 1204-
12
10. Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB (1987). “Purifica-
tion and characterization of a peptide from amyloid-rich pancreases of type 2
diabetic patients”. Proc Natl Acad Sci USA 84 (23): 8628-32
11. Hay DL, Christopoulos G, Christopoulos A, Sexton PM (2004). “Amylin recep-
tors: molecular composition and pharmacology”. Biochem Soc Trans 32 (5):
865-7
12. Peleg D, Kennedy CM, Hunter SK 1998 Intrauterine growth restriction: identifi-
cation and management. Am Fam Physician 58:453-60, 466-7
13. Langer O, Levy J, Brustman L, Anyaegbunam A, Merkatz R, Divon M 1989
Glycemic control în gestational diabetes mellitus--how tight is tight enough:
small for gestational age versus large for gestational age? Am J Obstet Gynecol
161:646-53
14. Leguizamon G, von Stecher F 2003 Third trimester glycemic profiles and fetal
growth. Curr Diab Rep 3:323-6
15. Thomas P, Peabody J, Turnier V, Clark RH 2000 A new look at intrauterine
growth and the impact of race, altitude, and gender. Pediatrics 106:E21
16. Sexton M, Hebel JR 1984 A clinical trial of change in maternal smoking and its
effect on birth weight. JAMA 251:911-5
17. Bauer MK, Harding JE, Bassett NS, et al. 1998 Fetal growth and placental func-
tion. Mol Cell Endocrinol 140:115-20
18. Sibley C, Glazier J, D’Souza S 1997 Placental transporter activity and expression
în relation to fetal growth. Exp Physiol 82:389-402
19. Sibley CP, Glazier JD, Greenwood SL, et al. 2002 Regulation of placental trans-
fer: the Na(+)/H(+) exchanger--a review. Placenta 23 Suppl A:S39-46
20. Cetin I 2003 Placental transport of amino acids in normal and growth-restrict-
ed pregnancies. Eur J Obstet Gynecol Reprod Biol 110 Suppl 1:S50-4
21. Jansson T 2001 Amino acid transporters în the human placenta. Pediatr Res
49:141-7
22. Zapf J, Rinderknecht E, Humbel RE, Froesch ER 1978 Nonsuppressible insulin-
like activity (NSILA) from human serum: recent accomplishments and their
physiologic implications. Metabolism 27:1803-28
23. Gude NM, Roberts CT, Kalionis B, King RG 2004 Growth and function of the
normal human placenta. Thromb Res 114:397-407
24. Han VK, Bassett N, Walton J, Challis JR 1996 The expression of insulin-like
growth factor (IGF) and IGF-binding protein (IGFBP) genes în the human
placenta and membranes: evidence for IGF-IGFBP interactions at the feto-
maternal interface. J Clin Endocrinol Metab 81:2680-93
25. Lee PD, Conover CA, Powell DR 1993 Regulation and function of insulin-like
growth factor-binding protein-1. Proc Soc Exp Biol Med 204:4-29
26. Liggins GC 1976 Adrenocortical-related maturational events în the fetus. Am
J Obstet Gynecol 126:931-41
27. Liggins GC 1994 The role of cortisol în preparing the fetus for birth. Reprod
Fertil Dev 6:141-50
28. Caspi E, Schreyer P, Weinraub Z, Bukovsky I, Tamir I 1975 Changes în amniotic
fluid lecithin-sphingomyelin ratio following maternal dexamethasone admin-
istration. Am J Obstet Gynecol 122:327-31
29. Matthews SG, Owen D, Kalabis G, et al. 2004 Fetal glucocorticoid exposure
and hypothalamo-pituitary-adrenal (HPA) function after birth. Endocr Res
30:827-36
30. Gitau R, Cameron A, Fisk NM, Glover V 1998 Fetal exposure to maternal cor-
tisol. Lancet 352:707-8
Vol. 4, Nr. 1/februarie 2008
pag. 31
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68